ERBB2 and breast cancer: Numerous studies indicate that a high Ki-67 index correlates with higher pCR rates after NAC in breast cancer, particularly in patients with aggressive tumor subtypes like human epidermal growth factor receptor 2 positive (HER2+) and triple-negative breast cancer (TNBC) [8-10].